newest glp 1 medication New GLP-1 Guidelines for Type 2 Diabetes in 2025 Understanding GLP-1 medications

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Kulkarni C.A., Brookes P.S

However, there are a number of reasons why people may stop taking these drugs

Retatrutide is being studied for: Type 2 diabetes MASH(Metabolic Dysfunction-Associated Steatohepatitis), a liver condition caused by fat buildup Heart disease risk reduction Knee osteoarthritis in people with higher body weight More research is needed before doctors know whether retatrutide is safe and effective for these conditions

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

The cost can reach upwards of $900 for just one months supply

Expert Opin Ivest Drugs 2005